Home | Swixx BioPharma | Modern Medicines for All

We are Committed to Create Healthier Futures for All.
Swixx Partners with Top Research-Based Biotech Companies.
Compliance is our Core Value & our Top Priority.
We Focus on Therapeutic Areas with High Unmet Needs.

News Read all news

Jun 27, 2023

Swixx Reveals Refreshed Corporate Visual and Website

May 9, 2023

Swixx and BeiGene partner in 13 countries of Central and Eastern Europe, Greece, Cyprus and Malta

May 8, 2023

Swixx appoints Marek Vasicek, MD, Chief Operating Officer Russia / Eurasia and R.O.W. (Rest of World) Expansion

About us

Swixx BioPharma is designed to fully replace biopharma, OTC and medical device multinationals’ subsidiaries or business units in those countries, or therapeutic areas of CEE, that the multinational chooses not to enter, or to exit.

Find out more

Therapeutic Areas

BioPharma’s focus is in 4 strategic therapeutic areas, launching highly innovative, new therapies in Rare disease, Hematology/Oncology, Specialty Care and Vaccines.

Find out more

Partnering

BioPharma’s focus is in 4 strategic therapeutic areas, launching highly innovative, new therapies in Rare disease, Hematology/Oncology, Specialty Care and Vaccines.

Find out more